HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen [Phase 3]
Phase IIIb trial assessing safety, efficacy, and tolerability after switching virologically suppressed patients to the fixed-dose combinatio…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children [Phase 2]
Open-label Phase 2 trial evaluating maraviroc with background therapy in HIV-1–infected CCR5-tropic children; aims to assess pharmacokinetic…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: The Effect of Antacids and Multivitamins on Raltegravir [Phase 1]
Phase 1 study evaluating potential interactions between antacids and multivitamins and the HIV antiretroviral raltegravir.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Home-based Partner Education and Testing (HOPE) Study [NA]
The HOPE study, a home-based partner education and testing trial for HIV conducted by the University of Washington, has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
A completed Johns Hopkins University clinical trial studied antiviral therapy for HIV and Hepatitis C coinfection with a focus on liver fibr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-02-23FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for COMPLERA, resulting in changes to its labeling.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT) [NA]
Clinical trial update evaluating backup with Combivir or single-dose Truvada to prevent NNRTI resistance after a single-dose Nevirapine for …
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment [Phase 4]
Phase 4 trial evaluating whether empiric tuberculosis treatment reduces early mortality and morbidity in people with HIV infection; results …
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Estimating the Global Need for Palliative Care for Children
This completed clinical trial estimates the global need for pediatric palliative care across cancer, congenital anomalies, cardiovascular di…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study [Phase 2]
Phase II pediatric safety and efficacy study of the REMUNE HIV/AIDS vaccine; current status is not disclosed.
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study [Phase 3]
This update describes a Phase III safety and efficacy trial of REMUNE in combination with Amplivax IR103 for HIV infection, sponsored by Imm…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD) [Phase 2]
Phase 2 open-label SWAD trial evaluated switching virologically suppressed HIV-1 adults from abacavir/lamivudine plus nevirapine to abacavir…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection [Phase 2]
Phase 2 clinical trial assessing the efficacy of tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive patients co-infecte…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Abacavir and Lamivudine PK in Children [Phase 2, Phase 3]
Phase 2/Phase 3 study reports pharmacokinetics of abacavir and lamivudine in HIV-infected children; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Progress Pediatric Study
This document reports a completed pediatric trial conducted by The HIV Netherlands Australia Thailand Research Collaboration addressing HIV …
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Surveillance of Kaletra in Korean Patients
A completed surveillance study evaluated Kaletra (lopinavir/ritonavir) in Korean patients with HIV-1 infection; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Intrauterine Insemination In HIV-Discordant Couples [NA]
This document reports the status of a clinical trial on intrauterine insemination in HIV-discordant couples, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Children With HIV and Asthma (CHIVAS) [NA]
The CHIVAS trial evaluating T cell responses to asthma in HIV-infected children before and after starting HIV treatment has completed.
-
FDA approval · 2016-02-19FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD, a fixed-dose combination antiviral for HIV-1 infection produced by Gilead Sciences…
-
FDA approval · 2016-02-19FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) by Janssen Products LP.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People [Phase 2, Phase 3]
An investigational vaccine designed to prevent disseminated tuberculosis in people with HIV has completed Phase 2 and Phase 3 trials.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: HIV-Associated Heart Disease
An NHLBI-sponsored clinical trial examining HIV-associated heart disease has completed. The study explored cardiovascular issues in people l…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Development of a Family Intervention to Address Drug Use and HIV in Vietnam [Phase 1, Phase 2]
The study reports completion of Phase 1 and Phase 2 of a family intervention designed to address drug use and HIV in Vietnam, with a focus o…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment [Phase 3]
Phase 3 open-label safety study of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (Genvoya) in HIV-1 patients with mild to mode…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: AIDS-Associated Cardiomyopathy
National Heart, Lung, and Blood Institute-sponsored trial studying AIDS-associated cardiomyopathy has completed.